SOPHIA GENETICS SA (SOPH) Forecast, Price Target & Analyst Ratings

NASDAQ:SOPH • CH1125843347

Current stock price

5.1 USD
+0.03 (+0.59%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SOPHIA GENETICS SA (SOPH).

Forecast Snapshot

Consensus Price Target

Price Target
$7.82
+ 53.33% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.25
Revenue Estimate
20.808M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$7.82
Upside
+ 53.33%
From current price of $5.10 to mean target of $7.82, Based on 10 analyst forecasts
Low
$7.07
Median
$7.14
High
$9.45

Price Target Revisions

1 Month
4.55%
3 Months
4.55%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for SOPH. The average price target is 7.82 USD. This implies a price increase of 53.33% is expected in the next year compared to the current price of 5.1.
The average price target has been revised upward by 4.55% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SOPH Current Analyst RatingSOPH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

SOPH Historical Analyst RatingsSOPH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
86.00%
SOPH was analyzed by 10 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about SOPH.
In the previous month the buy percentage consensus was at a similar level.
SOPH was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-15BTIGMaintains Buy -> Buy
2026-01-26GuggenheimMaintains Buy -> Buy
2025-11-10BTIGMaintains Buy -> Buy
2024-12-18Craig-HallumInitiate Buy
2024-08-07RBC CapitalMaintains Outperform -> Outperform
2024-06-27GuggenheimInitiate Buy
2024-03-06BTIGMaintains Buy -> Buy
2024-03-06RBC CapitalReiterate Outperform -> Outperform
2024-01-12RBC CapitalReiterate Outperform -> Outperform
2023-11-29RBC CapitalInitiate Outperform
2023-05-10Credit SuisseMaintains Neutral
2023-05-10Morgan StanleyMaintains Overweight
2023-03-08Morgan StanleyMaintains Overweight
2023-01-03BTIGInitiate Buy
2022-11-23Credit SuisseInitiate Neutral
2022-11-09Morgan StanleyMaintains Overweight
2022-08-10Morgan StanleyMaintains Overweight
2022-05-11Morgan StanleyMaintains Overweight
2022-02-15Morgan StanleyMaintains Overweight
2021-08-17Cowen & Co.Initiate Outperform
2021-08-17JP MorganInitiate Overweight
2021-08-17Credit SuisseInitiate Outperform
2021-08-17Morgan StanleyInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.25
Revenue Estimate
20.808M
Revenue Q2Q
17.04%
EPS Q2Q
4.87%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
2.00%
EPS (1 Month)
0.00%
EPS (3 Months)
-8.58%

Next Earnings Summary

SOPH is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.25 USD and the consensus revenue estimate is 20.81M USD.
The next earnings revenue estimate has been revised upward by 2% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
SOPH revenue by date.SOPH revenue by date.
62.371M
31.14%		65.173M
4.49%		77.271M
18.56%		95.115M
23.09%		113.73M
19.57%		141.37M
24.30%		184.31M
30.37%		238.99M
29.67%
EBITDA
YoY % growth
SOPH ebitda by date.SOPH ebitda by date.
-66.49M
19.16%		-57.972M
12.81%		-58.052M
-0.14%		-33.295M
42.65%		-21.609M
35.10%		-8.058M
62.71%		24.786M
407.59%		61.608M
148.56%
EBIT
YoY % growth
SOPH ebit by date.SOPH ebit by date.
-74.826M
14.80%		-66.568M
11.04%		-67.581M
-1.52%		-60.427M
10.59%		-48.204M
20.23%		-33.099M
31.34%		-5.712M
82.74%		29.478M
616.07%
Operating Margin
SOPH operating margin by date.SOPH operating margin by date.
-119.97%-102.14%-87.46%-63.53%-42.38%-23.41%-3.10%12.33%
EPS
YoY % growth
SOPH eps by date.SOPH eps by date.
-1.22
-4.27%		-0.95
22.13%		-1.12
-17.89%		-0.91
18.49%		-0.72
21.23%		-0.48
32.62%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.25
4.87%		-0.24
26.59%		-0.22
22.59%		-0.21
17.38%		-0.21
16.15%		-0.21
14.39%		-0.16
27.84%		-0.14
30.86%
Revenue
Q2Q % growth		20.808M
17.04%		22.287M
21.63%		25.041M
28.67%		27.005M
24.41%		24.616M
18.30%		26.316M
18.08%		29.988M
19.76%		33.014M
22.25%
EBITDA
Q2Q % growth		-9.914M
27.84%		-8.956M
35.22%		-7.298M
24.92%		-6.028M
10.19%		-7.796M
21.36%		-7.378M
17.62%		-4.267M
41.53%		-2.468M
59.05%
EBIT
Q2Q % growth		-16.391M
-2.22%		-16.001M
13.47%		-14.284M
15.04%		-13.776M
15.18%		-14.02M
14.47%		-13.707M
14.34%		-10.654M
25.41%		-9.707M
29.54%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SOPH Yearly Revenue VS EstimatesSOPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
SOPH Yearly EPS VS EstimatesSOPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.5 -1 -1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
16.16%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
22.34%
Revenue Next 5 Year
25.35%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
23.53%
EBIT Next 5 Year
23.54%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SOPHIA GENETICS SA / SOPH Forecast FAQ

Can you provide the average price target for SOPHIA GENETICS SA stock?

10 analysts have analysed SOPH and the average price target is 7.82 USD. This implies a price increase of 53.33% is expected in the next year compared to the current price of 5.1.

Can you provide the upcoming earnings date for SOPHIA GENETICS SA?

SOPHIA GENETICS SA (SOPH) will report earnings on 2026-05-04.

Can you provide the consensus estimates for SOPHIA GENETICS SA next earnings?

The consensus EPS estimate for the next earnings of SOPHIA GENETICS SA (SOPH) is -0.25 USD and the consensus revenue estimate is 20.81M USD.

Can you provide the analyst count for SOPHIA GENETICS SA stock?

The number of analysts covering SOPHIA GENETICS SA (SOPH) is 10.